How microRNA affects immune responses in fat tissue related to obesity
MICRORNA REGULATION OF ADIPOSE TISSUE IMMUNE RESPONSE IN OBESITY
This study is looking at a tiny molecule called microRNA-30a to see how it affects the immune system in fat tissue, which could help us understand and treat obesity and type 2 diabetes better.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Baylor College of Medicine NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-11194476 on NIH RePORTER |
What this research studies
This research investigates the role of microRNA-30a in regulating immune responses within white adipose tissue, which is crucial for understanding obesity-related insulin resistance and type 2 diabetes. By examining how this microRNA influences T regulatory cells in fat tissue, the study aims to uncover mechanisms that could lead to new immune therapies for obesity and its complications. The research involves both animal models and human samples to correlate findings and assess the impact of microRNA-30a on insulin sensitivity. If successful, this work could pave the way for innovative treatments targeting immune responses in obesity.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with obesity or insulin resistance, particularly those at risk for type 2 diabetes.
Not a fit: Patients who are not overweight or do not have insulin resistance or type 2 diabetes may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that improve insulin sensitivity and help manage obesity-related diabetes.
How similar studies have performed: Previous research has shown promising results in understanding immune responses in obesity, but this specific approach focusing on microRNA-30a is relatively novel.
Where this research is happening
Houston, United States
- Baylor College of Medicine — Houston, United States (Active)
Researchers
- Principal investigator: Wu, Huaizhu — Baylor College of Medicine
- Study coordinator: Wu, Huaizhu
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.